Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10069	Companies
205847	Keywords
136110	Articles
109148	Press releases

Home
Companies
Biophytis

BRIEF

published on 06/19/2024 at 23:05, 1 year 9 months ago

Biophytis prolonge son contrat avec Atlas pour le financement de ses activités

Biophytis Biotechnologie Financement ORNANE Atlas
BRIEF

published on 06/19/2024 at 23:05, 1 year 9 months ago

Biophytis Extends Financing Contract with Atlas

Biophytis Biotechnology Financing Clinical Trials Atlas
REGULATED PRESS RELEASE

published on 06/19/2024 at 23:00, 1 year 9 months ago

Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
Biophytis renouvelle son accord de financement avec Atlas pour sécuriser ses activités. La société émettra des obligations convertibles pour un montant maximum de 16 millions d'euros

Biophytis Financement Obligations Convertibles Atlas Programmes Cliniques
REGULATED PRESS RELEASE

published on 06/19/2024 at 23:00, 1 year 9 months ago

Biophytis extends its contract with Atlas to secure financing for its business activities
Biophytis extends bond financing agreement with Atlas, securing funding for clinical programs in obesity and Duchenne Muscular Dystrophy. Terms reflect confidence in growth potential

Biophytis Atlas Growth Potential Clinical Programs Bond Financing Agreement
BRIEF

published on 06/12/2024 at 10:16, 1 year 9 months ago

Biophytis annonce le succès du transfert industriel de production de BIO101

Biophytis Biotechnologie Dystrophie Musculaire De Duchenne BIO101 Seqens
BRIEF

published on 06/12/2024 at 10:16, 1 year 9 months ago

Biophytis announces the success of the industrial transfer of production of BIO101

Biophytis Biotechnology Duchenne Muscular Dystrophy BIO101 Seqens
PRESS RELEASE

published on 06/12/2024 at 10:11, 1 year 9 months ago

Biophytis annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens
Biophytis annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens. La société se focalise sur le traitement de maladies liées à l'âge, notamment la Dystrophie Musculaire de Duchenne

Biophytis BIO101 Seqens Transfert Industriel DMD
PRESS RELEASE

published on 06/12/2024 at 10:11, 1 year 9 months ago

Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens
Biophytis successfully transfers BIO101 (20-hydroxyecdysone) production to industrial scale with Seqens, enhancing therapeutic solutions for Duchenne Muscular Dystrophy patients

Biophytis Duchenne Muscular Dystrophy BIO101 Seqens 20-hydroxyecdysone
BRIEF

published on 06/12/2024 at 07:05, 1 year 9 months ago

Biophytis annonce le succès du transfert de production de BIO101 par Seqens

Biophytis Dystrophie Musculaire De Duchenne BIO101 Seqens Production Industrielle
BRIEF

published on 06/12/2024 at 07:05, 1 year 9 months ago

Biophytis Announces Successful Industrial Transfer of BIO101 Production by Seqens

Biophytis Clinical Trial Duchenne Muscular Dystrophy BIO101 Seqens

Accesswire

Published on 03/23/2026 at 22:40, 1 hour 28 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 1 hour 38 minutes ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 2 hours 8 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 2 hours 50 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 10 hours 3 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 22:05, 2 hours 2 minutes ago

DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 3 hours 2 minutes ago

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 3 hours 2 minutes ago

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 3 hours 7 minutes ago

Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 3 hours 12 minutes ago

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

Les Echos

Published on 03/23/2026 at 19:08, 4 hours 59 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 4 hours 59 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 5 hours 30 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 6 hours 22 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 6 hours 22 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE